Skip to main content
SpringerLink
Log in

Sujets « métaboliquement obèses » de poids normal. Première partie: diagnostic, physiopathologie et prévalence

Metabolically obese normal-weight subjects. Part One: diagnosis, pathophysiology and prevalence

  • Article Clinique / Clinical Article
  • Published:
Obésité

Résumé

L’obésité, notamment abdominale, est le facteur de risque principal du syndrome métabolique. Cependant, il existe manifestement des personnes non obèses qui sont métaboliquement anormales et, donc, vraisemblablement exposées à un risque accru de complications cardiovasculaires. Cet article vise à présenter les éléments conduisant au diagnostic du syndrome MONW (metabolically obese normal-weight), à tenter d’en cerner l’étiopathogénie et de mieux comprendre sa physiopathologie et, enfin, à analyser la prévalence de ce syndrome dans différentes populations.

Abstract

Obesity, particularly abdominal obesity, is the main risk factor for metabolic syndrome. However, some non-obese individuals are metabolically abnormal and therefore probably have an increased risk of cardiovascular disease. The present review paper aims to describe the main characteristics of the metabolically obese normal-weight (MONW) syndrome, analyse its etiopathogenesis and pathophysiology and, finally, assess its prevalence in various populations.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Références

  1. Van Gaal LF, Mertens IL, De Block CE (2006) Mechanisms linking obesity with cardiovascular disease. Nature 444: 875–880

    Article  PubMed  CAS  Google Scholar 

  2. Després JP, Lemieux I, Bergeron J, et al. (2008) Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk. Arterioscler Thromb Vasc Biol 28: 1039–1049

    Article  PubMed  CAS  Google Scholar 

  3. Alberti KGMM, Zimmet P, Shaw J, for the IDF Epidemiology Task Force Consensus Group (2005) The metabolic syndrome — a new worldwide definition. Lancet 366: 1059–1062

    Article  PubMed  Google Scholar 

  4. Grundy SM, Cleeman JI, Daniels SR, et al. (2005) Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112: 2735–2752

    Article  PubMed  Google Scholar 

  5. St-Onge MP, Janssen I, Heymsfield SB (2004) Metabolic syndrome in normal-weight Americans: new definition of the metabolically obese, normal-weight individual. Diabetes Care 24: 2222–2228

    Article  Google Scholar 

  6. Ruderman NB, Schneider SH, Berchtold P (1981) The “metabolically-obese”, normal-weight individual. Am J Clin Nutr 34: 1617–1621

    PubMed  CAS  Google Scholar 

  7. Ruderman NB, Berchtold P, Schneider S (1982) Obesity-associated disorders in normal-weight individuals: some speculations. Int J Obes 6(Suppl 1): 151–157

    PubMed  Google Scholar 

  8. Ruderman N, Chisholm D, Pi-Sunyer X, Schneider S (1998) The metabolically obese, normal-weight individual revisited. Diabetes 47: 699–713

    Article  PubMed  CAS  Google Scholar 

  9. Beck E, Scheen AJ (2008) Sujets « métaboliquement obèses » sans excès de poids: un phénotype interpellant. Rev Med Liège (sous presse)

  10. Conus F, Rabasa-Lhoret R, Peronnet F (2007) Characteristics of metabolically obese normal-weight (MONW) subjects. Appl Physiol Nutr Metab 32: 4–12

    Article  PubMed  Google Scholar 

  11. Prentice AM, Rayco-Solon P, Moore SE (2005) Insights from the developing world: thirfty genotypes and thrifty phenotypes. Proc Nutr Soc 64: 153–161

    Article  PubMed  CAS  Google Scholar 

  12. Dvorak RV, DeNino WF, Ades PA, Poehlman ET (1999) Phenotypic characteristics associated with insulin resistance in metabolically obese but normal-weight young women. Diabetes 48: 2210–2214

    Article  PubMed  CAS  Google Scholar 

  13. Conus F, Allison DB, Rabasa-Lhoret R, et al. (2004) Metabolic and behavioral characteristics of metabolically obese but normal-weight women. J Clin Endocrinol Metab 89: 5013–5020

    Article  PubMed  CAS  Google Scholar 

  14. Balkau B, Mhamdi L, Oppert JM, et al. (2008) Physical activity and insulin sensitivity. The RISC Study. Diabetes (Epub ahead of print)

  15. Hyun YJ, Koh SJ, Chae JS, et al. (2008) Atherogenecity of LDL and unfavorable adipokine profile in metabolically obese, normal-weight woman. Obesity 16: 784–789

    Article  PubMed  CAS  Google Scholar 

  16. Freedland ES (2004) Role of a critical visceral adipose tissue threshold (CVATT) in metabolic syndrome: implications for controlling dietary carbohydrates: a review. Nutr Metab (Lond) doi: 10.1186/1743-7075-1-12

  17. Chiolero A, Faeh D, Paccaud F, Cornuz J (2008) Consequences of smoking for body weight, body fat distribution, and insulin resistance. Am J Clin Nutr 87: 801–809

    PubMed  CAS  Google Scholar 

  18. Colditz GA, Willett WC, Rotnitzky A, Manson JE (1995) Weight gain as a risk factor for clinical diabetes mellitus in women. Ann Intern Med 122: 481–486

    PubMed  CAS  Google Scholar 

  19. Hillier TA, Fagot-Campagna A, Eschwège E, et al. (2006) Weight change and changes in the metabolic syndrome as the French population moves towards overweight: the DESIR cohort. Int J Epidemiol 35: 190–196

    Article  PubMed  CAS  Google Scholar 

  20. Klein S, Allison DB, Heymsfield SB, et al. (2007) Waist circumference and cardiometabolic risk: a consensus statement from shaping America’s health: Association for Weight Management and Obesity Prevention; NAASO, the Obesity Society; The American Society for Nutrition; and the American Diabetes Association. Diabetes Care 30: 1647–1652

    Article  PubMed  Google Scholar 

  21. Ryan MC, Fernster Farin HM, Abbasi F, Reaven GM (2008) Comparison of waist circumference versus body mass index in diagnosing metabolic syndrome and identifying apparently healthy subjects at increased risk of cardiovascular disease. Am J Cardiol 102: 40–46

    Article  PubMed  Google Scholar 

  22. Oppert JM, Charles MA, Thibult N, et al. (2002) Anthropometric estimates of muscle and fat mass in relation to cardiac and cancer mortality in men: the Paris Prospective Study. Am J Clin Nutr 75: 1107–1113

    PubMed  CAS  Google Scholar 

  23. De Lorenzo A, Martinoli R, Vaia F, Di Renzo L (2006) Normal-weight obese (NWO) women: an evaluation of a candidate new syndrome. Nutr Metab Cardiovasc Dis 16: 513–523

    Article  PubMed  CAS  Google Scholar 

  24. Di Renzo L, Del Gobbo V, Bigioni M, et al. (2006) Body composition analyses in normal-weight obese women. Eur Rev Med Pharmacol Sci 10: 191–196

    PubMed  Google Scholar 

  25. Fox CS, Massaro JM, Hoffmann U, et al. (2007) Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation 116: 39–48

    Article  PubMed  Google Scholar 

  26. Luyckx FH, Scheen AJ, Lefèbvre PJ (2000) Non-alcoholic steatohepatitis: association with obesity and insulin resistance, and influence of weight loss. Diabetes Metab 26: 98–106

    PubMed  CAS  Google Scholar 

  27. Yki-Järvinen H (2005) Fat in the liver and insulin resistance. Ann Med 37: 347–356

    Article  PubMed  CAS  Google Scholar 

  28. Katsuki A, Sumida Y, Urakawa H, et al. (2003) Increased visceral fat and serum levels of triglyceride are associated with insulin resistance in Japanese metabolically obese, normal-weight subjects with normal glucose tolerance. Diabetes Care 26: 2341–2344

    Article  PubMed  CAS  Google Scholar 

  29. Scheen AJ (2007) Évaluation de l’insulinosécrétion et de l’insulinosensibilité chez l’homme. Thérapie 62: 311–318

    Article  PubMed  Google Scholar 

  30. Katsuki A, Urakawa H, Gabazza EC, et al. (2005) Quantitative insulin sensitivity check index is a useful indicator of insulin resistance in Japanese metabolically obese, normal-weight subjects with normal glucose tolerance. Endocr J 52: 253–257

    Article  PubMed  Google Scholar 

  31. Luyckx FH, Scheen AJ (2003) L’hyperglycémie provoquée par voie orale: de la controverse à un plaidoyer pour sa place en biologie clinique. Immuno-Anal Biol Spec 18: 126–132

    Google Scholar 

  32. Abbasi F, Chu JW, Malendola C, et al. (2004) Discrimination between obesity and insulin resistance in the relationship with adiponectin. Diabetes 53: 585–590

    Article  PubMed  CAS  Google Scholar 

  33. Katsuki A, Sumida Y, Urakawa H, et al. (2003) Plasma levels of adiponectin are associated with insulin resistance and serum levels of triglyceride in Japanese metabolically obese, normal-weight men with normal glucose tolerance. Diabetes Care 26: 2964–2965

    Article  PubMed  Google Scholar 

  34. Katsuki A, Suematsu M, Gabazza EC, et al. (2006) Decreased high-molecular weight adiponectin-to-total adiponectin ratio in sera is associated with insulin resistance in Japanese metabolically obese, normal-weight men with normal glucose tolerance. Diabetes Care 29: 2327–2328

    Article  PubMed  Google Scholar 

  35. Tai ES, Lau TN, Ho SC, et al. (2000) Body fat distribution and cardiovascular risk in normal-weight women. Associations with insulin resistance, lipids and plasma leptin. Int J Obes Relat Metab Disord 24: 751–757

    Article  PubMed  CAS  Google Scholar 

  36. Eckel RH, Grundy SM, Zimmet PZ (2005) The metabolic syndrome. Lancet 365: 1415–1428

    Article  PubMed  CAS  Google Scholar 

  37. Karelis AD, St-Pierre DH, Conus F, et al. (2004) Metabolic and body composition factors in subgroups of obesity: what do we know? J Clin Endocrinol Metab 89: 2569–2575

    Article  PubMed  CAS  Google Scholar 

  38. Moro C, Bajpeyi S, Smith SR (2008) Determinants of intramyocellular triglyceride turnover: implications for insulin sensitivity. Am J Physiol Endocrinol Metab 294: 203–213

    Article  CAS  Google Scholar 

  39. Di Renzo L, Bigioni M, Bottini FG, et al. (2006) Normal-weight obese syndrome: role of single nucleotide polymorphism of IL-1 5Ralpha and MTHFR 677C->T genes in the relationship between body composition and resting metabolic rate. Eur Rev Med Pharmacol Sci 10: 235–245

    PubMed  Google Scholar 

  40. Guerre-Millo M (2008) Adiponectin: an update. Diabetes Metab 34: 12–18

    PubMed  CAS  Google Scholar 

  41. Succurro E, Marini MA, Frontoni S, et al. (2008) Insulin secretion in metabolically obese, but normal-weight and in metabolically healthy but obese individuals. Obesity 16: 1881–1886

    Article  PubMed  CAS  Google Scholar 

  42. Ferrannini E, Natali A, Bell P, et al. (1997) Insulin resistance and hypersecretion in obesity. European Group for the Study of Insulin Resistance (EGIR). J Clin Invest 100: 1166–1173

    Article  PubMed  CAS  Google Scholar 

  43. Walker BR, Andrew R (2006) Tissue production of cortisol by 11-beta-hydroxysteroid dehydrogenase type 1 and metabolic disease. Ann NY Acad Sci 1083: 165–184

    Article  PubMed  CAS  Google Scholar 

  44. Desbriere R, Vuaroqueaux V, Achard V, et al. (2006) 11-beta-hydroxysteroid dehydrogenase type 1 mRNA is increased in both visceral and subcutaneous adipose tissue of obese patients. Obesity 14: 794–798

    Article  PubMed  CAS  Google Scholar 

  45. Paterson JM, Morton NM, Fievet C, et al. (2004) Metabolic syndrome without obesity: hepatic overexpression of 11-beta-hydroxysteroid dehydrogenase type 1 in transgenic mice. Proc Natl Acad Sci USA 101: 7088–7093

    Article  PubMed  CAS  Google Scholar 

  46. Katsuki A, Suematsu M, Gabazza EC, et al. (2006) Increased oxidative stress is associated with decreased circulating levels of adiponectin in Japanese metabolically obese, normal-weight men with normal glucose tolerance. Diabetes Res Clin Pract 73: 310–314

    Article  PubMed  CAS  Google Scholar 

  47. De Lorenzo A, Del Gobbo V, Premrov MG, et al. (2007) Normal-weight obese syndrome: early inflammation? Am J Clin Nutr 85: 40–45

    PubMed  Google Scholar 

  48. The DECODE Study Group (2008) Does the constellation of risk factors with and without abdominal adiposity associate with different cardiovascular mortality risk? Int J Obesity 32: 757–762

    Article  Google Scholar 

  49. McLaughlin T, Allison G, Abbasi F, et al. (2004) Prevalence of insulin resistance and associated cardiovascular disease risk factors among normal-weight, overweight and obese individuals. Metabolism 53: 495–499

    Article  PubMed  CAS  Google Scholar 

  50. Meigs JB, Wilson PWF, Fox CS, et al. (2006) Body mass index, metabolic syndrome and risk of type 2 diabetes or cardiovascular disease. J Clin Endocrinol Metab 91: 2906–2912

    Article  PubMed  CAS  Google Scholar 

  51. Katzmarzyk PT, Church TS, Janssen I, et al. (2005) Metabolic syndrome, obesity and mortality. Impact of cardiorespiratory fitness. Diabetes Care 28: 391–397

    Article  PubMed  Google Scholar 

  52. Ford ES (2005) Prevalence of the metabolic syndrome defined by the International Diabetes Federation among Adults in the US. Diabetes Care 28: 2745–2749

    Article  PubMed  Google Scholar 

  53. Park YW, Zhu S, Palaniappan L, et al. (2003) The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988–1994. Arch Intern Med 163: 427–436

    Article  PubMed  Google Scholar 

  54. Janssen I, Katzmarzyk PT, Ross R (2002) Body mass index, waist circumference, and health risk. Evidence in support of current National Institutes of Health guidelines. Arch Intern Med 162: 2074–2079

    Article  PubMed  Google Scholar 

  55. Janssen I, Katzmarzyk PT, Ross R (2004) Waist circumference and not body mass index explains obesity-related health risk. Am J Clin Nutr 79: 379–384

    PubMed  CAS  Google Scholar 

  56. Widman RP, Muntner P, Reynolds K, et al. (2008) The obese without cardiometabolic risk factor clustering and the normal-weight with cardiometabolic risk factor clustering. Prevalence and correlates of 2 phenotypes among the US population (NHANES 1999–2004). Arch Intern Med 168: 1617–1624

    Article  Google Scholar 

  57. Balkau B, Picard P, Vol S, et al. (2007) Consequences of change in waist circumference on cardiometabolic risk factors over 9 years. Data from an Epidemiological Study on the Insulin Resistance Syndrome (DESIR). Diabetes Care 30: 1901–1903

    Article  PubMed  CAS  Google Scholar 

  58. Pannier B, Thomas F, Eschwège E, et al. (2006) Cardiovascular risk markers associated with the metabolic syndrome in a large French population: the SYMFONIE study. Diabetes Metab 32: 467–474

    Article  PubMed  CAS  Google Scholar 

  59. Bo S, Ciccone G, Pearce N, et al. (2007) Prevalence of undiagnosed metabolic syndrome in a population of adult asymptomatic subjects. Diab Res Clin Pract 75: 362–365

    Article  Google Scholar 

  60. St-Pierre AC, Cantin B, Mauriège P, et al. (2005) Insulin resistance syndrome, body mass index and the risk of ischemic heart disease. CMAJ 172: 1301–1305

    PubMed  Google Scholar 

  61. Hadaegh F, Zabetian A, Harati H, Azizi F (2007) Metabolic syndrome in normal-weight Iranian adults. Ann Saudi Med 27: 18–24

    Article  PubMed  Google Scholar 

  62. Zimmet P, Alberti G, Kaufman F, et al. (2007) The metabolic syndrome in children and adolescents. Lancet 369: 2059–2061

    Article  PubMed  Google Scholar 

  63. Morrison JA, Ford ES, Steinberger J (2008) The pediatric metabolic syndrome. Minerva Med 99: 269–287

    PubMed  CAS  Google Scholar 

  64. Kelishadi R, Cook SR, Esmaeil M, et al. (2008) Metabolically obese normal-weight and phenotypically obese metabolically normal youths: the CASPIAN study. J Am Diet Assoc 108: 82–90

    Article  PubMed  CAS  Google Scholar 

  65. Calcaterra V, Klersy C, Muratori T, et al. (2008) Prevalence of metabolic syndrome (MS) in children and adolescents with varying degrees of obesity. Clin Endocrinol (Oxf) 68: 868–872

    Article  CAS  Google Scholar 

  66. Maffeis C, Banzato C, Talamini G, et al. (2008) Waist-to-height ratio, a useful index to identify high metabolic risk in overweight children. J Pediatr 152: 207–213

    Article  PubMed  Google Scholar 

  67. Messiah SE, Arheart KL, Luke B, et al. (2008) Relationship between body mass index and metabolic syndrome risk factors among US 8-to 14-year-olds, 1999 to 2002. J Pediatr 153: 215–221

    Article  PubMed  Google Scholar 

  68. Lee S, Bacha F, Gungor N, Arslanian S (2008) Comparison of different definitions of pediatric metabolic syndrome: relation to abdominal adiposity, insulin resistance, adiponectin and inflammatory biomarkers. J Pediatr 152: 177–184

    Article  PubMed  CAS  Google Scholar 

  69. DuBose KD, Eisenmann JC, Donnelly JE (2007) Aerobic fitness attenuates the metabolic syndrome score in normal-weight, at-risk-for-overweight and overweight children. Pediatrics 120: e1262–e1268

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Service de diabétologie, nutrition et maladies métaboliques, département de médecine, CHU Sart-Tilman, B-4000, Liège, Belgique

    E. Beck, N. Paquot & A. J. Scheen

  2. Université de Liège, 9, place du 20-Août, B-4000, Liège, Belgique

    N. Paquot & A. J. Scheen

  3. Unité de pharmacologie clinique, département de médecine, CHU Sart-Tilman, B-4000, Liège, Belgique

    A. J. Scheen

Authors
  1. E. Beck
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. N. Paquot
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. J. Scheen
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A. J. Scheen.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Beck, E., Paquot, N. & Scheen, A.J. Sujets « métaboliquement obèses » de poids normal. Première partie: diagnostic, physiopathologie et prévalence. Obes 3, 184–193 (2008). https://doi.org/10.1007/s11690-008-0137-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11690-008-0137-1

Mots clés

Keywords

Search

Navigation